Incontinence: How do β3-adrenoceptor agonists work in the bladder?
Department of Continence Medicine, The University of Tokyo Graduate School of Medicine, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Yasuhiko
Y
Igawa
Department of Continence Medicine, The University of Tokyo Graduate School of Medicine, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Naoki
N
Aizawa
D058667:Adrenergic beta-3 Receptor Agonists / Q000494:pharmacology* / Q000627:therapeutic use; D015415:Biomarkers / Q000378:metabolism; D059329:Cholinergic Neurons / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D022702:Receptors, Adrenergic, beta-3 / Q000378:metabolism; D001743:Urinary Bladder / Q000187:drug effects* / Q000294:innervation / Q000378:metabolism; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*; D014549:Urinary Incontinence / Q000188:drug therapy*
D058667:Adrenergic beta-3 Receptor Agonists; D015415:Biomarkers; D022702:Receptors, Adrenergic, beta-3